...
机译:多发性骨髓瘤患者的预后评分系统与修订后的国际分期系统分类为II阶段
Department of Haematology‐OncologyChonnam National University Hwasun HospitalHwasun Korea;
Division of Haematology‐OncologySamsung Medical CentreSeoul Korea;
Division of HaematologyYonsei University College of MedicineSeoul Korea;
Division of Haematology‐OncologySamsung Medical CentreSeoul Korea;
Division of HaematologyYonsei University College of MedicineSeoul Korea;
Division of HaematologyYonsei University College of MedicineSeoul Korea;
Department of Haematology‐OncologyChonnam National University Hwasun HospitalHwasun Korea;
Department of Haematology‐OncologyChonnam National University Hwasun HospitalHwasun Korea;
Department of Haematology‐OncologyChonnam National University Hwasun HospitalHwasun Korea;
Department of Haematology‐OncologyChonnam National University Hwasun HospitalHwasun Korea;
Department of Haematology‐OncologyChonnam National University Hwasun HospitalHwasun Korea;
multiple myeloma; prognosis; risk factors;
机译:多发性骨髓瘤患者的预后评分系统与修订后的国际分期系统分类为II阶段
机译:修订后的国际分期系统与经典的国际分期系统相比更好地歧视移植无型骨髓瘤患者之间的风险群体
机译:经修订的国际分期系统是预测和预测的早期复发(<24个月)在自体移植进行新诊断的多发性骨髓瘤后
机译:对PKU Muhammadiyah Bantul Houstural急诊科创伤患者修订创伤评分评估系统的应用
机译:多发性骨髓瘤中HDAC和蛋白酶体抑制的药效系统分析。
机译:经修订的多发性骨髓瘤国际分期系统:国际骨髓瘤工作组的报告
机译:经修订的国际分期系统是预测和预测的早期复发(<24个月)在自体移植进行新诊断的多发性骨髓瘤后